Journal Article (Review Article) DKFZ-2026-00785

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Advancing cancer equity in seven high-income countries: an analysis of policy levers and National Cancer Control Plans.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2026
The Lancet Publ. Group London

The lancet / Oncology 27(4), e207 - e217 () [10.1016/S1470-2045(26)00072-0]
 GO

Abstract: Persistent inequities in cancer outcomes remain a defining challenge for global health systems, including in high-income countries. Despite advances across prevention, early detection, treatment, and survivorship, disparities persist, reflecting entrenched social and structural inequities. While equity is increasingly articulated within national and global cancer agendas, comparative analysis of how equity is conceptualised and operationalised in national cancer control planning remains limited. This Policy Review addresses this gap by synthesising evidence across seven high-income countries comprising the G7 Cancer collaboration-Australia, Canada, France, Germany, Japan, the UK, and the USA-drawing on policy frameworks, National Cancer Control Plans (NCCPs), and semi-structured expert interviews. The Policy Review identifies marked variation in equity definitions and application, with most countries emphasising access to care, fewer addressing outcomes or patient experience, and equity often being framed as secondary to broader health system goals. Terminology is inconsistently applied and action on structural determinants is limited. Barriers to NCCP implementation encompass fragmented accountability, restricted policy mandates, and fiscal or cultural sensitivities. Enablers of effective NCCP implementation include data infrastructure systems, multistakeholder engagement, legislative frameworks, and cross-sector collaboration. Synthesising these findings, we present an evidence-informed Policy Framework for Equity in Cancer Control, to guide equitable cancer policy in high-income settings.

Keyword(s): Humans (MeSH) ; Neoplasms: economics (MeSH) ; Neoplasms: therapy (MeSH) ; Neoplasms: epidemiology (MeSH) ; Neoplasms: prevention & control (MeSH) ; Health Policy: economics (MeSH) ; Health Equity: economics (MeSH) ; Developed Countries: economics (MeSH) ; Healthcare Disparities: economics (MeSH) ; United States: epidemiology (MeSH) ; Canada: epidemiology (MeSH) ; Health Services Accessibility: economics (MeSH) ; Global Health (MeSH) ; Australia: epidemiology (MeSH) ; Japan: epidemiology (MeSH) ; United Kingdom: epidemiology (MeSH) ; Germany: epidemiology (MeSH)

Classification:

Contributing Institute(s):
  1. Policy und Implementierungsforschung in der Krebsprävention (C170)
  2. Epidemiologisches Krebsregister BW (M110)
Research Program(s):
  1. 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)

Appears in the scientific report 2026
Database coverage:
Medline ; OpenAccess ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 50 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database
Open Access

 Record created 2026-04-07, last modified 2026-05-29


OpenAccess:
Download fulltext PDF Download fulltext PDF (PDFA)
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)